#USA #UCB #Pleasanton #Vault CRM #Veeva

UCB Partners with Veeva to Transform Engagement Dynamics

In a strategic move to revolutionize its approach to customer engagement in the life sciences sector, UCB has announced its commitment to adopting Veeva Vault CRM, a sophisticated agentic engagement platform provided by Veeva Systems (NYSE: VEEV). This partnership is set to leverage cutting-edge technologies aimed at enhancing customer experiences and accelerating the commercialization of pharmaceutical activities.

Unveiling Enhanced Client Engagement

The essence of this collaboration lies in Veeva Vault CRM’s potential to unify engagement efforts across various touchpoints in the healthcare journey. Edwin Erckens, UCB's Chief Digital Technology Officer, expressed excitement about this partnership, highlighting the shared commitment of both companies to customer success. He stated, “We are excited to strengthen our strategic partnership with Veeva by moving to Vault CRM.” This emphasizes UCB's drive to harness innovative technology for better operational execution.

Vault CRM is uniquely designed with industry-specific AI capabilities that are crucial for tailoring customer experiences and supporting data-driven decisions. Chris Moore, President of Veeva Europe, commented, “Vault CRM will provide UCB with a stable, scalable, and future-ready technology foundation that will advance UCB's commercial strategy.” This integration signifies a notable advancement in how UCB engages with healthcare professionals and stakeholders, addressing historical barriers in treatment access and delivery.

Features of Vault CRM Suite

The Vault CRM Suite encompasses a variety of tools aimed at optimizing customer interactions. A standout feature, the Agentic Call Report, allows teams to compile Commercial Evidence, which is instrumental in identifying and addressing hidden treatment barriers. Such functionalities promise to empower UCB in executing its commercial initiatives effectively.

By utilizing Veeva Vault CRM, UCB is not only committing to innovative software but also to an agile operational model that fosters collaboration and responsiveness to market demands. This shift represents a significant departure from traditional methods, leaning into a future where data and technology play foundational roles in pharmaceutical engagements.

About Veeva Systems

For those unfamiliar, Veeva Systems is recognized as a leading provider of cloud-based solutions tailored for the life sciences industry. With over 1,500 clients ranging from major pharmaceutical players to innovative biotech firms, Veeva excels in delivering integrated solutions that enhance commercial execution and ensure patient access to essential treatments. Committed to innovation and product excellence, Veeva serves as a Public Benefit Corporation, aiming to balance the interests of customers, shareholders, employees, and the broader community in its operations.

To learn more about Veeva and its offerings, visit veeva.com.

Looking Ahead

The implications of UCB's decision to partner with Veeva extend beyond immediate operational upgrades. This collaboration signifies a broader industry trend toward digitization and data-centric strategies in pharmaceuticals. As UCB progresses with the implementation of Vault CRM, stakeholders across the healthcare ecosystem will be watching closely to gauge the effectiveness of these enhancements in improving patient outcomes and overall engagement.

In an industry where patient accessibility and streamlined engagement are paramount, UCB's transition to Veeva Vault CRM illustrates a robust step forward. As both companies work closely to execute this vision, the healthcare landscape may witness transformative changes in how pharmaceutical companies interact with and serve their customers.